KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Receivables (2016 - 2025)

Elevance Health (ELV) has disclosed Receivables for 17 consecutive years, with $16.4 billion as the latest value for Q4 2025.

  • Quarterly Receivables rose 16.77% to $16.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.4 billion through Dec 2025, up 16.77% year-over-year, with the annual reading at $16.4 billion for FY2025, 16.77% up from the prior year.
  • Receivables for Q4 2025 was $16.4 billion at Elevance Health, down from $17.2 billion in the prior quarter.
  • The five-year high for Receivables was $17.7 billion in Q2 2025, with the low at $7.2 billion in Q4 2021.
  • Average Receivables over 5 years is $12.7 billion, with a median of $13.0 billion recorded in 2023.
  • The sharpest move saw Receivables dropped 11.44% in 2021, then soared 58.49% in 2022.
  • Over 5 years, Receivables stood at $7.2 billion in 2021, then skyrocketed by 58.49% to $11.4 billion in 2022, then grew by 16.92% to $13.3 billion in 2023, then increased by 5.41% to $14.0 billion in 2024, then rose by 16.77% to $16.4 billion in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $16.4 billion, $17.2 billion, and $17.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.